Sort
21,453 grants matching “tuberculosis”
Novel next-generation sequencing assay for monitoring multidrug resistant tuberculosis treatment in the setting of HIV infection
$731,288John Zapata Metcalfe · University Of California, San Francisco · R01 · FY2020 · AI
Oral Microbiome and Lung Cancer Risk
$731,073Qiuyin Cai · Vanderbilt University Medical Center · R01 · FY2017 · CA
Improving the molecular diagnosis of drug resistant tuberculosis
$731,000Midori Kato-Maeda · University Of California, San Francisco · R01 · FY2016 · AI
Development of a New Diamine (SQ109) for the Treatment of C. difficile Infection
$730,895Marina N Protopopova · Sequella, Inc. · R01 · FY2011 · AI
Personalized Antimicrobial Combinations to Combat Resistance
$730,882Vincent H Tam · University Of Houston · R01 · FY2019 · AI
A multifactorial pipeline to dissect combinatorial drug efficacy in Tuberculosis
$730,836David R Sherman · University Of Washington · R01 · FY2021 · AI
The Consequences of Reinfection with M. tuberculosis
$730,762Joanne L. Flynn · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · AI
TB SCREENING AND PREVENTION IN ACTIVE USERS
$730,654Beth Israel Medical Ctr (New York) · R01 · FY2001 · DA
RESEARCH PROJECT 1
$730,553Nevan J Krogan · University Of California, San Francisco · U19 · FY2019 · AI
An Acoustofluidic Device for Point-of-Care Sputum Processing and Analysis
$730,534Lin Wang · Ascent Bio-Nano Technologies, Inc. · R44 · FY2016 · HL
Chemical genetics of M. tuberculosis DosRST signaling and persistence
$730,444Robert B Abramovitch · Michigan State University · R01 · FY2022 · AI
Genetic Requirements for the survival of Tubercle Bacilli in Nonhuman Primates
$730,427Deepak Kaushal · Tulane University Of Louisiana · R01 · FY2013 · AI
A novel cartridge-based sequencing solution for decentralized M. tuberculosis resistance detection
$730,369John Zapata Metcalfe · University Of California, San Francisco · R01 · FY2023 · AI
BUILDING GLOBAL CAPACITY FOR DIAGNOSTIC TESTING OF TUBERCULOSIS, MALARIA AND HIV
$730,000Akos L Somoskovi · Foundation/Innovative New Diagnostics · U2G · FY2011 · PS
Chemical biology studies of MmpL3 inhibition and resistance in mycobacteria
$729,894Robert B Abramovitch · Michigan State University · R01 · FY2025 · AI
Marshallese: Alternate Surveillance for COVID-19 in a Unique Population
$729,868Ka'imi Alohilani Sinclair · Washington State University · R01 · FY2022 · MD
Aerosol spectinamide-1599 therapy against tuberculosis
$729,832Mercedes Gonzalez-Juarrero · Colorado State University · R01 · FY2019 · AI
Advanced Genotypic and Phenotypic monitoring of Drug Resistant TB to Improve TB Treatment Outcomes
$729,791Michelle H Larsen · Albert Einstein College Of Medicine · R01 · FY2022 · AI
Enhanced POC assay for TB in HIV-infected children based on the ultrasensitive detection of the urinary form of the lipoarabinomannan antigen
$729,737Abraham Pinter · Rbhs-New Jersey Medical School · R01 · FY2020 · AI
Hypoxia, tuberculosis, and T cell dysfunction
$729,692Samuel M Behar · Univ Of Massachusetts Med Sch Worcester · R01 · FY2023 · AI
International Research in Korea: Clinical Studies of Drug-Resistant Tuberculosis
$729,683Clifton Barry · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
TUBERCULOSIS CONTROL AND ELIMINATION IN THE STATE OF HAWAII
$729,596Loretta J Fuddy · Hawaii State Department Of Health · U52 · FY2013 · PS
Novel nanoparticular diagnostics for cerebral toxoplasmosis and Chagas in HIV patients living in Latin America
$729,479Robert H Gilman · Johns Hopkins University · R01 · FY2018 · AI
PS05-003 TUBERCULOSIS ELIMINATION AND LABORATORY
$729,368Weston R Ruhrig · Pennsylvania State Dept Of Health · U52 · FY2007 · PS
B cells and humoral immunity in tuberculosis
$729,368John R. Chan · Albert Einstein College Of Medicine · R01 · FY2012 · AI